<ul><li>Stereotaxis Inc. has submitted its EMAGIN 5F and MAGiC catheters for FDA clearance.</li><li>EMAGIN 5F is a robotically navigated catheter designed for minimally invasive cardiac ablation procedures.</li><li>The company plans to expand the applications of its Robotic Magnetic Navigation technology in stroke, cancer, and cardiovascular disease treatments.</li><li>In addition to FDA clearance, Stereotaxis expects to obtain CE mark clearance for the catheters in Europe and launch them in the second half of 2025.</li></ul>

Stereotaxis submits catheter pair for FDA clearance

Discover more